We are live on
!
Find out more
OCMI
Oaktop Capital Management II Portfolio holdings
AUM
$1.34B
1-Year Est. Return
114.5%
This Fund
S&P 500
This Quarter
Est. Return
+8.77%
1 Year Est. Return
+114.5%
3 Year Est. Return
+223.73%
5 Year Est. Return
+264.71%
10 Year Est. Return
+1,370.55%
AUM
$453M
AUM Growth
+$27.2M
(+6.4%)
Cap. Flow
+$299K
Cap. Flow
% of AUM
0.07%
Top 10 Holdings %
Top 10 Hldgs %
91.57%
Holding
20
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$1,000K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BBBY
Bed Bath & Beyond
BBBY
|
+$701K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 68.65% |
| 2 | Healthcare | 12.13% |
| 3 | Industrials | 7.11% |
| 4 | Consumer Discretionary | 0% |
Similar funds
FFW
NEWAS
BFMH
HAM
4WM
WA
VHAM
AWA
Oaktop Capital Management II's Q3 2020 Portfolio in Review
As of Q3 2020, Oaktop Capital Management II held 20 positions worth $453M, up 6.4% from $425M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Oaktop Capital Management II's Q3 2020 filing shows 1 increased and 1 closed positions. The largest sale was Bed Bath & Beyond, an estimated $701K.
By sector, the portfolio is most concentrated in Technology at 69% of assets, down from 70% a quarter earlier, followed by Healthcare and Industrials.
- Oaktop Capital Management II added most to Bristol-Myers Squibb Company Contingent Value Rights in Q3 2020, an estimated $1,000K increase.
- Oaktop Capital Management II fully exited Bed Bath & Beyond in Q3 2020, selling an estimated $701K.
- Oaktop Capital Management II's ten largest holdings make up 92% of its $453M portfolio in Q3 2020.
- Oaktop Capital Management II opened 0 new positions and closed 1 in Q3 2020.
- Oaktop Capital Management II's portfolio value rose 6.4% quarter-over-quarter to $453M.
Based on Oaktop Capital Management II's 13F filing for Q3 2020, filed 12 Nov 2020.